Remedy Entertainment Oyj financials
Remedy Entertainment Oyj
7437003VZ3JPF7DBTG92 | Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | €59.5M | €50.7M |
| Other income | €0 | €2.0K |
| Employee benefits expense | €24.9M | €24.7M |
| Operating profit (EBIT) | -€14.9M | -€4.3M |
| Net finance income / (cost) | -€841.0K | €460.0K |
| Finance costs | €2.0M | €420.0K |
| Profit before tax | -€15.7M | -€3.8M |
| Income tax expense | -€2.7M | -€224.0K |
| Profit for the year | -€13.0M | -€3.6M |
| — attributable to owners | -€13.0M | -€3.6M |
| Total comprehensive income | -€13.0M | -€3.6M |
| Per share | ||
| Basic EPS | €-0.96 | €-0.27 |
| Diluted EPS | €-0.96 | €-0.27 |
| Cash flow statement | ||
| Net cash from operating activities | €4.5M | €11.0M |
| Net cash from investing activities | -€13.6M | -€22.9M |
| Net cash from financing activities | -€2.2M | €12.9M |
| Lease liability payments | €1.4M | €1.4M |
| Balance sheet | ||
| Total assets | €87.5M | €99.3M |
| Non-current assets | €42.8M | €52.0M |
| Property, plant & equipment | €2.4M | €3.4M |
| Right-of-use assets | €3.4M | €2.5M |
| Current assets | €44.8M | €47.3M |
| Trade & other receivables | €6.5M | €4.1M |
| Cash & equivalents | €9.6M | €21.0M |
| Total equity | €56.6M | €68.5M |
| Non-current liabilities | €17.2M | €14.6M |
| Lease liabilities (non-current) | €2.1M | €1.1M |
| Current liabilities | €13.8M | €16.2M |
| Lease liabilities (current) | €1.3M | €1.4M |
| Trade & other payables | €12.5M | €14.8M |
| Deferred tax liabilities | €196.0K | €127.0K |
| Derived metrics | ||
| Operating margin | -25.0% | -8.4% |
| Net margin | -21.9% | -7.1% |
| Return on equity | -23.0% | -5.2% |
| Cash conversion ratio | -0.35× | -3.06× |
| Other reported items | ||
| Comprehensive Income Attributable To Owners of Parent | -€13.0M | -€3.6M |
| Current Contract Assets | €8.9M | €2.1M |
| Current Financial Assets At Fair Value Through Profit Or Loss | €19.8M | €20.1M |
| Deferred Tax Assets | €8.3M | €5.4M |
| Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €26.2M | €6.8M |
| Dividends Recognised As Distributions To Owners Per Share | €0.00 | €0.00 |
| Equity and Liabilities | €87.5M | €99.3M |
| Finance Income | €1.1M | €879.0K |
| Income Taxes Paid Refund Classified As Operating Activities | €176.0K | €72.0K |
| Increase Decrease In Cash and Cash Equivalents | -€11.4M | €930.0K |
| Increase Decrease Through Conversion of Convertible Instruments | — | €1.5M |
| Increase Decrease Through Exercise of Options | -€710.0K | — |
| Increase Decrease Through Sharebased Payment Transactions | €2.0M | €2.4M |
| Increase Decrease Through Transactions With Owners | €1.1M | €4.4M |
| Intangible Assets Other Than Goodwill | €27.9M | €39.8M |
| Interest Received Classified As Operating Activities | €346.0K | €513.0K |
| Issue of Equity | €510.0K | €529.0K |
| Issued Capital | €80.0K | €80.0K |
| Liabilities | €31.0M | €30.8M |
| Noncurrent Portion of Noncurrent Bonds Issued | €14.8M | €13.3M |
| Noncurrent Receivables | €751.0K | €987.0K |
| Other Cash Payments From Operating Activities | €44.1M | €46.8M |
| Other Cash Receipts From Operating Activities | €0 | €2.0K |
| Other Comprehensive Income | €0 | €0 |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | €0 | €0 |
| Other Expense By Nature | €11.0M | €6.9M |
| Payments For Debt Issue Costs | €0 | €464.0K |
| Payments For Development Project Expenditure | €11.0M | €8.0M |
| Payments To Acquire Or Redeem Entitys Shares | €686.0K | €0 |
| Proceeds From Exercise of Options | -€710.0K | €0 |
| Proceeds From Issuing Shares | €612.0K | €680.0K |
| Purchase of Treasury Shares | €686.0K | — |
| Receipts From Sales of Goods and Rendering of Services | €48.9M | €57.5M |
| Repayments of Current Borrowings | €0 | €918.0K |
| Retained Earnings | -€1.7M | €10.1M |
| Share Premium | €38.0K | €38.0K |
Every line item above is a fact tagged in Remedy Entertainment Oyj's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.